Generation of a CRISPR/Cas edited human induced pluripotent stem cell line DHMi005-A-1 carrying a patient-specific disease-causing point mutation in the TBX5 gene

Harald Lahm, Paul Heinrich, Elisabeth Zierler, Elda Dzilic, Irina Neb, Tatjana Luzius, Stefanie A. Doppler, Stephanie Schneider, Rüdiger Lange, Markus Krane, Martina Dreßen

Publikation: Beitrag in FachzeitschriftArtikelBegutachtung

3 Zitate (Scopus)

Abstract

A number of mutations in the human TBX5 gene have been described which cause Holt-Oram syndrome, a severe congenital disease associated with abnormalities in heart and upper limb development. We have used a prime-editing approach to introduce a patient-specific disease-causing TBX5 mutation (c.920_C > A) into an induced pluripotent stem cell (iPSC) line from a healthy donor. The resulting iPSC line provides a powerful tool to identify and analyze the biological and molecular impact of this specific TBX5 mutation in comparison to the isogenic control iPSC line during cardiac development.

OriginalspracheEnglisch
Aufsatznummer102691
FachzeitschriftStem Cell Research
Jahrgang60
DOIs
PublikationsstatusVeröffentlicht - Apr. 2022

Fingerprint

Untersuchen Sie die Forschungsthemen von „Generation of a CRISPR/Cas edited human induced pluripotent stem cell line DHMi005-A-1 carrying a patient-specific disease-causing point mutation in the TBX5 gene“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren